Search Within

Joachim Yahalom

  1. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (123)
  2. Journal Article (100)
  3. Book Section (17)
  4. Research Letter (4)
  5. Conference Paper (3)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (248)
  2. Radiation Oncology, Department of (248)
  3. Survivorship Research (248)
  4. Department of Medicine (243)
  5. Hematologic Malignancies, Division of (243)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. David Straus (82)
  3. Ariela Noy (71)
  4. Craig Moskowitz (71)
  5. Steven Horwitz (65)
  6. Maria Palomba (63)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (28)
  4. 2022 (11)
  5. 2021 (13)
  6. 2020 (12)

More Years

Publications
  1. Blood (77)
  2. International Journal of Radiation Oncology, Biology, Physics (25)
  3. Hematological Oncology (20)
  4. Journal of Clinical Oncology (16)
  5. Journal of the National Comprehensive Cancer Network (14)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (85)
  2. Elsevier Inc. (40)
  3. Wiley Blackwell (23)
  4. American Society of Clinical Oncology (16)
  5. Harborside Press (14)
  6. Nature Publishing Group (12)

More Publishers

Results (248)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of accelerated fractionation involved field radiotherapy (IFRT), total body irradiation (TBI), ifosfamide and continuous infusion etoposide with autologous stem cell transplantation (ASCT) in the treatment of patients with relapsed and primary refractory aggressive non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Kewalramani, T.; Malhotra, S.; Nimer, S. D.
    Blood (2001)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory Hodgkin's disease (HD) treated with high dose chemoradiotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hedrick, E. E.; Gonzalez, M.; Yahalom, J.
    Blood (2000)

    Fulltext@MSK | Save
  • Outcome of adult patients (pts) with chemosensitive (CS) relapsed or primary refractory Hodgkin's disease (HD) or aggressive NHL (NHL) after failure of autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Malhotra, S.; Qin, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2000)

    Fulltext@MSK | Save
  • High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: An intention-to-treat analysis
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Hedrick, E. E.; Donnelly, G. B.; Hunte, S.; Priovolos, A. C.; Qin, J.; Lyons, N. C.; Yahalom, J.; Nimer, S. D.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 3rd ed (1999)

    Fulltext@MSK | Save
  • The management of Hodgkin's disease during pregnancy
    Book Section

    Portlock, C. S.; Yahalom, J.
    In Mauch, P. M.; Armitage, J. O.; Diehl, V.; Hoppe, R. T.; Weiss, L. M. (Eds.) Hodgkin's Disease (1999)

    Fulltext@MSK | Save
  • NCCN practice guidelines for Hodgkin's disease
    Journal Article

    Hoppe, R. T.; Abrams, R.; Bernstein, S.; Bierman, P.; Bloomfield, C. D.; Cox, J.; Gordon, L.; Horning, S.; Kaminski, M.; Love, G.; more...
    Oncology (Norwalk) (1999)

    Fulltext@MSK | Save
  • Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Donnelly, G. B.; Hedrick, E. E.; Kewalramani, T.; Satagopan, J. M.; Walits, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (1999)

    Fulltext@MSK | Save